nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS1—Alzheimer's disease	0.514	0.636	CbGaD
Trisalicylate-choline—PTGS2—Alzheimer's disease	0.294	0.364	CbGaD
Trisalicylate-choline—Skin papilloma—Rivastigmine—Alzheimer's disease	0.00563	0.0337	CcSEcCtD
Trisalicylate-choline—Duodenal ulcer—Donepezil—Alzheimer's disease	0.00427	0.0256	CcSEcCtD
Trisalicylate-choline—Epigastric pain—Donepezil—Alzheimer's disease	0.00427	0.0256	CcSEcCtD
Trisalicylate-choline—Upset stomach—Galantamine—Alzheimer's disease	0.00407	0.0243	CcSEcCtD
Trisalicylate-choline—Duodenal ulcer—Rivastigmine—Alzheimer's disease	0.0038	0.0227	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Donepezil—Alzheimer's disease	0.00355	0.0213	CcSEcCtD
Trisalicylate-choline—Hypothermia—Memantine—Alzheimer's disease	0.00335	0.02	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Memantine—Alzheimer's disease	0.00335	0.02	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Rivastigmine—Alzheimer's disease	0.00327	0.0196	CcSEcCtD
Trisalicylate-choline—Hypothermia—Rivastigmine—Alzheimer's disease	0.00327	0.0196	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Memantine—Alzheimer's disease	0.00323	0.0193	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Rivastigmine—Alzheimer's disease	0.00316	0.0189	CcSEcCtD
Trisalicylate-choline—Upset stomach—Donepezil—Alzheimer's disease	0.00315	0.0189	CcSEcCtD
Trisalicylate-choline—Stupor—Memantine—Alzheimer's disease	0.00251	0.015	CcSEcCtD
Trisalicylate-choline—Stinging—Rivastigmine—Alzheimer's disease	0.00226	0.0136	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Donepezil—Alzheimer's disease	0.00217	0.013	CcSEcCtD
Trisalicylate-choline—Lethargy—Galantamine—Alzheimer's disease	0.00197	0.0118	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Memantine—Alzheimer's disease	0.00197	0.0118	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Donepezil—Alzheimer's disease	0.00189	0.0113	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Donepezil—Alzheimer's disease	0.00187	0.0112	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Memantine—Alzheimer's disease	0.00181	0.0108	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Memantine—Alzheimer's disease	0.00179	0.0107	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00177	0.0106	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.00175	0.0105	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Memantine—Alzheimer's disease	0.00171	0.0103	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Rivastigmine—Alzheimer's disease	0.00168	0.01	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Galantamine—Alzheimer's disease	0.0016	0.0096	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—PTGS1—Alzheimer's disease	0.00154	0.344	CrCbGaD
Trisalicylate-choline—Deafness—Memantine—Alzheimer's disease	0.00152	0.00911	CcSEcCtD
Trisalicylate-choline—Deafness—Rivastigmine—Alzheimer's disease	0.00149	0.00891	CcSEcCtD
Trisalicylate-choline—Epistaxis—Galantamine—Alzheimer's disease	0.00141	0.00842	CcSEcCtD
Trisalicylate-choline—Lethargy—Memantine—Alzheimer's disease	0.00139	0.00832	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00137	0.0082	CcSEcCtD
Trisalicylate-choline—Hepatitis—Galantamine—Alzheimer's disease	0.00134	0.00801	CcSEcCtD
Trisalicylate-choline—Hallucination—Galantamine—Alzheimer's disease	0.00133	0.00797	CcSEcCtD
Trisalicylate-choline—Salsalate—PTGS1—Alzheimer's disease	0.00131	0.292	CrCbGaD
Trisalicylate-choline—Asthma—Donepezil—Alzheimer's disease	0.0013	0.00776	CcSEcCtD
Trisalicylate-choline—Tinnitus—Galantamine—Alzheimer's disease	0.00125	0.00747	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00124	0.00744	CcSEcCtD
Trisalicylate-choline—Flushing—Galantamine—Alzheimer's disease	0.00124	0.00744	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00122	0.00728	CcSEcCtD
Trisalicylate-choline—Weight increased—Donepezil—Alzheimer's disease	0.00118	0.00706	CcSEcCtD
Trisalicylate-choline—Asthma—Memantine—Alzheimer's disease	0.00118	0.00704	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Galantamine—Alzheimer's disease	0.00114	0.00683	CcSEcCtD
Trisalicylate-choline—Sweating—Donepezil—Alzheimer's disease	0.00111	0.00663	CcSEcCtD
Trisalicylate-choline—Epistaxis—Donepezil—Alzheimer's disease	0.00109	0.00652	CcSEcCtD
Trisalicylate-choline—Weight increased—Memantine—Alzheimer's disease	0.00107	0.00641	CcSEcCtD
Trisalicylate-choline—Weight increased—Rivastigmine—Alzheimer's disease	0.00105	0.00627	CcSEcCtD
Trisalicylate-choline—Hepatitis—Donepezil—Alzheimer's disease	0.00104	0.00621	CcSEcCtD
Trisalicylate-choline—Hallucination—Donepezil—Alzheimer's disease	0.00103	0.00618	CcSEcCtD
Trisalicylate-choline—Drowsiness—Rivastigmine—Alzheimer's disease	0.00103	0.00614	CcSEcCtD
Trisalicylate-choline—Epistaxis—Memantine—Alzheimer's disease	0.00099	0.00592	CcSEcCtD
Trisalicylate-choline—Sweating—Rivastigmine—Alzheimer's disease	0.000984	0.00589	CcSEcCtD
Trisalicylate-choline—Epistaxis—Rivastigmine—Alzheimer's disease	0.000968	0.00579	CcSEcCtD
Trisalicylate-choline—Tinnitus—Donepezil—Alzheimer's disease	0.000967	0.00579	CcSEcCtD
Trisalicylate-choline—Confusional state—Galantamine—Alzheimer's disease	0.000959	0.00574	CcSEcCtD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—RCAN1—Alzheimer's disease	0.00095	0.0465	CbGpPWpGaD
Trisalicylate-choline—Hepatitis—Memantine—Alzheimer's disease	0.000942	0.00564	CcSEcCtD
Trisalicylate-choline—Hallucination—Memantine—Alzheimer's disease	0.000937	0.00561	CcSEcCtD
Trisalicylate-choline—Shock—Galantamine—Alzheimer's disease	0.000936	0.0056	CcSEcCtD
Trisalicylate-choline—Hepatitis—Rivastigmine—Alzheimer's disease	0.000921	0.00551	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000919	0.0055	CcSEcCtD
Trisalicylate-choline—Hallucination—Rivastigmine—Alzheimer's disease	0.000917	0.00549	CcSEcCtD
Trisalicylate-choline—Anorexia—Galantamine—Alzheimer's disease	0.000907	0.00543	CcSEcCtD
Trisalicylate-choline—Erythema—Donepezil—Alzheimer's disease	0.000903	0.0054	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Memantine—Alzheimer's disease	0.000891	0.00533	CcSEcCtD
Trisalicylate-choline—Hypotension—Galantamine—Alzheimer's disease	0.000889	0.00532	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Donepezil—Alzheimer's disease	0.000884	0.00529	CcSEcCtD
Trisalicylate-choline—Tinnitus—Memantine—Alzheimer's disease	0.000878	0.00526	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—Alzheimer's disease	0.000878	0.197	CrCbGaD
Trisalicylate-choline—Flushing—Memantine—Alzheimer's disease	0.000874	0.00523	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000871	0.00521	CcSEcCtD
Trisalicylate-choline—Tinnitus—Rivastigmine—Alzheimer's disease	0.000859	0.00514	CcSEcCtD
Trisalicylate-choline—Flushing—Rivastigmine—Alzheimer's disease	0.000855	0.00512	CcSEcCtD
Trisalicylate-choline—Somnolence—Galantamine—Alzheimer's disease	0.000845	0.00506	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Galantamine—Alzheimer's disease	0.000837	0.00501	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Galantamine—Alzheimer's disease	0.000827	0.00495	CcSEcCtD
Trisalicylate-choline—Constipation—Galantamine—Alzheimer's disease	0.000813	0.00487	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Memantine—Alzheimer's disease	0.000803	0.00481	CcSEcCtD
Trisalicylate-choline—Erythema—Rivastigmine—Alzheimer's disease	0.000802	0.0048	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000786	0.0047	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Galantamine—Alzheimer's disease	0.000784	0.00469	CcSEcCtD
Trisalicylate-choline—Salsalate—PTGS2—Alzheimer's disease	0.000746	0.167	CrCbGaD
Trisalicylate-choline—Confusional state—Donepezil—Alzheimer's disease	0.000743	0.00445	CcSEcCtD
Trisalicylate-choline—Oedema—Donepezil—Alzheimer's disease	0.000737	0.00441	CcSEcCtD
Trisalicylate-choline—Shock—Donepezil—Alzheimer's disease	0.000725	0.00434	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000712	0.00426	CcSEcCtD
Trisalicylate-choline—Anorexia—Donepezil—Alzheimer's disease	0.000703	0.0042	CcSEcCtD
Trisalicylate-choline—Hypotension—Donepezil—Alzheimer's disease	0.000689	0.00412	CcSEcCtD
Trisalicylate-choline—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—Alzheimer's disease	0.000677	0.0331	CbGpPWpGaD
Trisalicylate-choline—Confusional state—Memantine—Alzheimer's disease	0.000675	0.00404	CcSEcCtD
Trisalicylate-choline—Oedema—Memantine—Alzheimer's disease	0.000669	0.00401	CcSEcCtD
Trisalicylate-choline—Confusional state—Rivastigmine—Alzheimer's disease	0.00066	0.00395	CcSEcCtD
Trisalicylate-choline—Shock—Memantine—Alzheimer's disease	0.000658	0.00394	CcSEcCtD
Trisalicylate-choline—Somnolence—Donepezil—Alzheimer's disease	0.000655	0.00392	CcSEcCtD
Trisalicylate-choline—Oedema—Rivastigmine—Alzheimer's disease	0.000655	0.00392	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Galantamine—Alzheimer's disease	0.000651	0.00389	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Donepezil—Alzheimer's disease	0.000649	0.00388	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Memantine—Alzheimer's disease	0.000647	0.00387	CcSEcCtD
Trisalicylate-choline—Shock—Rivastigmine—Alzheimer's disease	0.000644	0.00385	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Donepezil—Alzheimer's disease	0.000641	0.00383	CcSEcCtD
Trisalicylate-choline—Anorexia—Memantine—Alzheimer's disease	0.000638	0.00382	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000633	0.00379	CcSEcCtD
Trisalicylate-choline—Constipation—Donepezil—Alzheimer's disease	0.00063	0.00377	CcSEcCtD
Trisalicylate-choline—Pain—Donepezil—Alzheimer's disease	0.00063	0.00377	CcSEcCtD
Trisalicylate-choline—Dizziness—Galantamine—Alzheimer's disease	0.000629	0.00376	CcSEcCtD
Trisalicylate-choline—Hypotension—Memantine—Alzheimer's disease	0.000625	0.00374	CcSEcCtD
Trisalicylate-choline—Anorexia—Rivastigmine—Alzheimer's disease	0.000624	0.00373	CcSEcCtD
Trisalicylate-choline—Hypotension—Rivastigmine—Alzheimer's disease	0.000612	0.00366	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Donepezil—Alzheimer's disease	0.000607	0.00363	CcSEcCtD
Trisalicylate-choline—Vomiting—Galantamine—Alzheimer's disease	0.000605	0.00362	CcSEcCtD
Trisalicylate-choline—Rash—Galantamine—Alzheimer's disease	0.0006	0.00359	CcSEcCtD
Trisalicylate-choline—Dermatitis—Galantamine—Alzheimer's disease	0.000599	0.00359	CcSEcCtD
Trisalicylate-choline—Headache—Galantamine—Alzheimer's disease	0.000596	0.00357	CcSEcCtD
Trisalicylate-choline—Somnolence—Memantine—Alzheimer's disease	0.000595	0.00356	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Memantine—Alzheimer's disease	0.000589	0.00353	CcSEcCtD
Trisalicylate-choline—Urticaria—Donepezil—Alzheimer's disease	0.000586	0.0035	CcSEcCtD
Trisalicylate-choline—Somnolence—Rivastigmine—Alzheimer's disease	0.000582	0.00348	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Memantine—Alzheimer's disease	0.000582	0.00348	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000576	0.00345	CcSEcCtD
Trisalicylate-choline—Pain—Memantine—Alzheimer's disease	0.000572	0.00342	CcSEcCtD
Trisalicylate-choline—Constipation—Memantine—Alzheimer's disease	0.000572	0.00342	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000569	0.00341	CcSEcCtD
Trisalicylate-choline—Nausea—Galantamine—Alzheimer's disease	0.000565	0.00338	CcSEcCtD
Trisalicylate-choline—Constipation—Rivastigmine—Alzheimer's disease	0.00056	0.00335	CcSEcCtD
Trisalicylate-choline—Pain—Rivastigmine—Alzheimer's disease	0.00056	0.00335	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SERPINA3—Alzheimer's disease	0.000552	0.027	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Memantine—Alzheimer's disease	0.000551	0.0033	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000539	0.00323	CcSEcCtD
Trisalicylate-choline—Urticaria—Memantine—Alzheimer's disease	0.000532	0.00318	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—PTGS1—Alzheimer's disease	0.00053	0.0259	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Donepezil—Alzheimer's disease	0.000521	0.00312	CcSEcCtD
Trisalicylate-choline—Urticaria—Rivastigmine—Alzheimer's disease	0.00052	0.00311	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Donepezil—Alzheimer's disease	0.000504	0.00302	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—HMOX1—Alzheimer's disease	0.000487	0.0238	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Donepezil—Alzheimer's disease	0.000487	0.00292	CcSEcCtD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000477	0.0233	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Memantine—Alzheimer's disease	0.000473	0.00283	CcSEcCtD
Trisalicylate-choline—Vomiting—Donepezil—Alzheimer's disease	0.000469	0.0028	CcSEcCtD
Trisalicylate-choline—Rash—Donepezil—Alzheimer's disease	0.000465	0.00278	CcSEcCtD
Trisalicylate-choline—Dermatitis—Donepezil—Alzheimer's disease	0.000464	0.00278	CcSEcCtD
Trisalicylate-choline—Pruritus—Rivastigmine—Alzheimer's disease	0.000463	0.00277	CcSEcCtD
Trisalicylate-choline—Headache—Donepezil—Alzheimer's disease	0.000462	0.00276	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Memantine—Alzheimer's disease	0.000458	0.00274	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000448	0.00268	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—BAX—Alzheimer's disease	0.000443	0.0216	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Memantine—Alzheimer's disease	0.000443	0.00265	CcSEcCtD
Trisalicylate-choline—PTGS2—Eicosanoid Synthesis—PTGS1—Alzheimer's disease	0.00044	0.0215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SERPINA3—Alzheimer's disease	0.000439	0.0214	CbGpPWpGaD
Trisalicylate-choline—Nausea—Donepezil—Alzheimer's disease	0.000438	0.00262	CcSEcCtD
Trisalicylate-choline—Dizziness—Rivastigmine—Alzheimer's disease	0.000433	0.00259	CcSEcCtD
Trisalicylate-choline—Vomiting—Memantine—Alzheimer's disease	0.000425	0.00255	CcSEcCtD
Trisalicylate-choline—Rash—Memantine—Alzheimer's disease	0.000422	0.00253	CcSEcCtD
Trisalicylate-choline—Dermatitis—Memantine—Alzheimer's disease	0.000422	0.00252	CcSEcCtD
Trisalicylate-choline—Headache—Memantine—Alzheimer's disease	0.000419	0.00251	CcSEcCtD
Trisalicylate-choline—Vomiting—Rivastigmine—Alzheimer's disease	0.000416	0.00249	CcSEcCtD
Trisalicylate-choline—Rash—Rivastigmine—Alzheimer's disease	0.000413	0.00247	CcSEcCtD
Trisalicylate-choline—Dermatitis—Rivastigmine—Alzheimer's disease	0.000412	0.00247	CcSEcCtD
Trisalicylate-choline—Headache—Rivastigmine—Alzheimer's disease	0.00041	0.00245	CcSEcCtD
Trisalicylate-choline—Nausea—Memantine—Alzheimer's disease	0.000397	0.00238	CcSEcCtD
Trisalicylate-choline—Nausea—Rivastigmine—Alzheimer's disease	0.000389	0.00233	CcSEcCtD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—HMOX1—Alzheimer's disease	0.000387	0.0189	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—Alzheimer's disease	0.000368	0.018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—BAX—Alzheimer's disease	0.000351	0.0172	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Alzheimer's disease	0.000327	0.016	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000285	0.0139	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—BCL2—Alzheimer's disease	0.00027	0.0132	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—PTGS2—Alzheimer's disease	0.000256	0.0125	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP46A1—Alzheimer's disease	0.000254	0.0124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000245	0.012	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—PPARGC1A—Alzheimer's disease	0.000238	0.0117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—MEF2C—Alzheimer's disease	0.000215	0.0105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—BCL2—Alzheimer's disease	0.000214	0.0105	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—MPO—Alzheimer's disease	0.000213	0.0104	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Eicosanoid Synthesis—PTGS2—Alzheimer's disease	0.000212	0.0104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM1—Alzheimer's disease	0.000212	0.0104	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000212	0.0104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—Alzheimer's disease	0.000184	0.00898	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Alzheimer's disease	0.000178	0.00869	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MPO—Alzheimer's disease	0.000175	0.00858	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	0.000174	0.00853	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—Alzheimer's disease	0.000174	0.00849	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—TNF—Alzheimer's disease	0.000173	0.00845	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—GFAP—Alzheimer's disease	0.000171	0.00838	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—Alzheimer's disease	0.00017	0.00829	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MPO—Alzheimer's disease	0.000169	0.00827	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ABCA1—Alzheimer's disease	0.000167	0.00815	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—PPP3CA—Alzheimer's disease	0.000161	0.00786	CbGpPWpGaD
Trisalicylate-choline—PTGS2—S1P1 pathway—VEGFA—Alzheimer's disease	0.00016	0.00783	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—CREB1—Alzheimer's disease	0.000156	0.00764	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—PTGS1—Alzheimer's disease	0.000156	0.00761	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—MAOB—Alzheimer's disease	0.000151	0.0074	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SOD1—Alzheimer's disease	0.000149	0.00726	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000146	0.00714	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	0.00014	0.00683	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—IL6—Alzheimer's disease	0.000139	0.00682	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM1—Alzheimer's disease	0.000137	0.00671	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—TNF—Alzheimer's disease	0.000137	0.00671	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SOD2—Alzheimer's disease	0.000134	0.00654	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ABCA1—Alzheimer's disease	0.000132	0.00647	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—PPP3CA—Alzheimer's disease	0.000122	0.00599	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Alzheimer's disease	0.000119	0.00583	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000118	0.00577	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SOD1—Alzheimer's disease	0.000118	0.00577	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—MTHFR—Alzheimer's disease	0.000118	0.00576	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000116	0.00567	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP2D6—Alzheimer's disease	0.000112	0.0055	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—IL6—Alzheimer's disease	0.000111	0.00541	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000108	0.0053	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SOD2—Alzheimer's disease	0.000106	0.00519	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000106	0.00516	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—F2—Alzheimer's disease	0.000103	0.00506	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NGFR—Alzheimer's disease	0.000101	0.00492	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.0001	0.0049	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	9.74e-05	0.00476	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	9.72e-05	0.00476	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Alzheimer's disease	9.43e-05	0.00461	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—INS—Alzheimer's disease	9.37e-05	0.00458	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MTHFR—Alzheimer's disease	9.35e-05	0.00457	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CCL2—Alzheimer's disease	9.21e-05	0.00451	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	9.1e-05	0.00445	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	8.93e-05	0.00437	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—BDNF—Alzheimer's disease	8.76e-05	0.00428	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—Alzheimer's disease	8.7e-05	0.00425	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1A—Alzheimer's disease	8.41e-05	0.00411	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	8.38e-05	0.0041	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—F2—Alzheimer's disease	8.21e-05	0.00401	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	7.92e-05	0.00387	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	7.89e-05	0.00386	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	7.78e-05	0.00381	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	7.73e-05	0.00378	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—Alzheimer's disease	7.51e-05	0.00367	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—INS—Alzheimer's disease	7.43e-05	0.00364	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	7.42e-05	0.00363	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CCL2—Alzheimer's disease	7.31e-05	0.00358	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—Alzheimer's disease	6.99e-05	0.00342	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—LEP—Alzheimer's disease	6.88e-05	0.00337	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	6.76e-05	0.00331	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—BCL2—Alzheimer's disease	6.52e-05	0.00319	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—DHCR24—Alzheimer's disease	6.5e-05	0.00318	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS2—Alzheimer's disease	6.41e-05	0.00314	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Alzheimer's disease	6.33e-05	0.00309	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ITM2B—Alzheimer's disease	6.16e-05	0.00301	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	6.06e-05	0.00296	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	5.96e-05	0.00291	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCL2—Alzheimer's disease	5.78e-05	0.00283	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	5.55e-05	0.00271	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	5.55e-05	0.00271	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA4—Alzheimer's disease	5.53e-05	0.0027	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.4e-05	0.00264	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GAPDHS—Alzheimer's disease	5.2e-05	0.00254	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—DHCR24—Alzheimer's disease	5.16e-05	0.00252	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—Alzheimer's disease	5.07e-05	0.00248	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ATP5A1—Alzheimer's disease	4.93e-05	0.00241	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GAPDHS—Alzheimer's disease	4.93e-05	0.00241	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.81e-05	0.00235	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLD3—Alzheimer's disease	4.7e-05	0.0023	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.7e-05	0.0023	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.64e-05	0.00227	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD17B10—Alzheimer's disease	4.51e-05	0.0022	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	4.47e-05	0.00219	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—Alzheimer's disease	4.39e-05	0.00215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA4—Alzheimer's disease	4.39e-05	0.00215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CASP3—Alzheimer's disease	4.38e-05	0.00214	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP46A1—Alzheimer's disease	4.34e-05	0.00212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.29e-05	0.0021	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TTR—Alzheimer's disease	4.27e-05	0.00209	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ND1—Alzheimer's disease	4.19e-05	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	4.12e-05	0.00202	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.09e-05	0.002	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—Alzheimer's disease	4.09e-05	0.002	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	4.03e-05	0.00197	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	4.02e-05	0.00197	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	3.91e-05	0.00191	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.87e-05	0.00189	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.74e-05	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLD3—Alzheimer's disease	3.73e-05	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.73e-05	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.69e-05	0.0018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	3.58e-05	0.00175	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.5e-05	0.00171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	3.44e-05	0.00168	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	3.41e-05	0.00167	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.38e-05	0.00165	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ND1—Alzheimer's disease	3.32e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.25e-05	0.00159	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	3.25e-05	0.00159	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.23e-05	0.00158	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	3.18e-05	0.00156	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SNCA—Alzheimer's disease	3.17e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.98e-05	0.00146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.97e-05	0.00145	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.94e-05	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PSENEN—Alzheimer's disease	2.83e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	2.81e-05	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APH1A—Alzheimer's disease	2.79e-05	0.00136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.74e-05	0.00134	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NCSTN—Alzheimer's disease	2.72e-05	0.00133	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TPI1—Alzheimer's disease	2.7e-05	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CHAT—Alzheimer's disease	2.7e-05	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LRP1—Alzheimer's disease	2.65e-05	0.0013	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MAOB—Alzheimer's disease	2.59e-05	0.00127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	2.57e-05	0.00126	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.56e-05	0.00125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TPI1—Alzheimer's disease	2.56e-05	0.00125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.53e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GAPDH—Alzheimer's disease	2.49e-05	0.00122	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.46e-05	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.44e-05	0.00119	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—A2M—Alzheimer's disease	2.41e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EIF2AK2—Alzheimer's disease	2.41e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GAPDH—Alzheimer's disease	2.36e-05	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.33e-05	0.00114	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.32e-05	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PSEN2—Alzheimer's disease	2.21e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.17e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CST3—Alzheimer's disease	2.16e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.15e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TPI1—Alzheimer's disease	2.14e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CHAT—Alzheimer's disease	2.14e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACHE—Alzheimer's disease	2.09e-05	0.00102	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—INPP5D—Alzheimer's disease	2.07e-05	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MAOB—Alzheimer's disease	2.05e-05	0.001	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IAPP—Alzheimer's disease	2.02e-05	0.000988	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GAPDH—Alzheimer's disease	1.98e-05	0.000967	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ENO1—Alzheimer's disease	1.96e-05	0.000959	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.95e-05	0.000956	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.94e-05	0.000947	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	1.92e-05	0.00094	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—A2M—Alzheimer's disease	1.91e-05	0.000934	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.91e-05	0.000934	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ENO1—Alzheimer's disease	1.86e-05	0.000909	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPP3CA—Alzheimer's disease	1.85e-05	0.000904	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—BCHE—Alzheimer's disease	1.82e-05	0.000891	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GAB2—Alzheimer's disease	1.77e-05	0.000867	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GSK3A—Alzheimer's disease	1.76e-05	0.00086	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APP—Alzheimer's disease	1.73e-05	0.000845	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLCB1—Alzheimer's disease	1.72e-05	0.000841	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.7e-05	0.000833	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.69e-05	0.000825	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.67e-05	0.000815	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.66e-05	0.000812	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.64e-05	0.000803	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.61e-05	0.000788	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.56e-05	0.000761	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.56e-05	0.000761	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.53e-05	0.000747	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ADAM10—Alzheimer's disease	1.49e-05	0.000727	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.45e-05	0.000708	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.44e-05	0.000703	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.43e-05	0.0007	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLCB1—Alzheimer's disease	1.37e-05	0.000668	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCA1—Alzheimer's disease	1.32e-05	0.000647	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPL—Alzheimer's disease	1.31e-05	0.00064	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LPL—Alzheimer's disease	1.24e-05	0.000606	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCG—Alzheimer's disease	1.21e-05	0.00059	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—Alzheimer's disease	1.18e-05	0.000576	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CCR5—Alzheimer's disease	1.14e-05	0.000559	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	1.14e-05	0.000558	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMOX1—Alzheimer's disease	1.14e-05	0.000555	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—Alzheimer's disease	1.12e-05	0.000546	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CALM1—Alzheimer's disease	1.1e-05	0.000538	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOE—Alzheimer's disease	1.1e-05	0.000536	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAV1—Alzheimer's disease	1.09e-05	0.000531	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CALM1—Alzheimer's disease	1.04e-05	0.00051	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOE—Alzheimer's disease	1.04e-05	0.000508	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPL—Alzheimer's disease	1.04e-05	0.000508	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CAV1—Alzheimer's disease	1.03e-05	0.000504	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS2—Alzheimer's disease	9.69e-06	0.000474	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOTCH1—Alzheimer's disease	9.59e-06	0.000469	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARG—Alzheimer's disease	9.55e-06	0.000467	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—INS—Alzheimer's disease	9.37e-06	0.000458	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—Alzheimer's disease	9.35e-06	0.000457	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GSK3B—Alzheimer's disease	9e-06	0.00044	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CREB1—Alzheimer's disease	8.93e-06	0.000437	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—INS—Alzheimer's disease	8.88e-06	0.000434	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CALM1—Alzheimer's disease	8.74e-06	0.000427	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOE—Alzheimer's disease	8.71e-06	0.000426	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAV1—Alzheimer's disease	8.63e-06	0.000422	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—Alzheimer's disease	8.22e-06	0.000402	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—Alzheimer's disease	7.79e-06	0.000381	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARG—Alzheimer's disease	7.58e-06	0.000371	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—Alzheimer's disease	7.51e-06	0.000367	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—INS—Alzheimer's disease	7.44e-06	0.000364	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—Alzheimer's disease	6.52e-06	0.000319	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—Alzheimer's disease	5.15e-06	0.000252	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—Alzheimer's disease	3.88e-06	0.00019	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—Alzheimer's disease	3.78e-06	0.000185	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—Alzheimer's disease	3.58e-06	0.000175	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—Alzheimer's disease	3e-06	0.000147	CbGpPWpGaD
